COMPARATIVE COST ANALYSIS OF THE MAIN ANTIDEPRESSANTS AVAILABLE ON THE BRAZILIAN MARKET
DOI:
https://doi.org/10.61164/rmnm.v12i4.3319Keywords:
Antidepressants; Pharmaceuticals; Economic impacts.Abstract
Depression is a common disease affecting millions of people worldwide, with women being more prone to it, especially during postpartum. This study aims to compare the costs of the main antidepressants available in the Brazilian market, identify the most prescribed ones, analyze the differences between brand-name and generic medications, and evaluate the economic impact of prolonged antidepressant use. Data was collected from three Brazilian pharmacies and analyzed in relation to the current minimum wage in the country, showing that the monthly cost of antidepressant treatment can represent 9% of a patient's salary. This information is important to assess medication accessibility, the economic impact on patients, and on the Unified Health System. Furthermore, estimates of costs for psychiatric medications can assist in mental health research and in comparing costs with other health actions. This study is crucial for both academic development and healthcare professionals.
References
BAKKER, M. H., HUGTENBURG, J. G., SMITS, M. G., VAN DER HORST, H. E., & SLOTTJE, P. (2023). Off‐label low dose amitriptyline for insomnia disorder: Patient‐reported outcomes. Pharmacoepidemiology and drug safety, 32(4), 435-445. DOI: https://doi.org/10.1002/pds.5561
BOTERO, B. F., FIGUEIREDO, E. F. G., DA COSTA, J. E. B., DE OLIVEIRA MAGALHÃES, M. N., DE ALMEIDA, P. H. F., MARTIM, S. R., & DA SILVA, Y. T. P. (2022). Eficácia e riscos do uso de psicofármacos em crianças e adolescentes com transtornos de depressão: uma revisão bibliográfica. Research, Society and Development, 11(14).
DWYER, J. B., LANDEROS-WEISENBERGER, A., JOHNSON, J. A., LONDONO TOBON, A., FLORES, J. M., NASIR, M., ... & BLOCH, M. H. (2021). Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial. American Journal of Psychiatry, 178(4), 352-362. DOI: https://doi.org/10.1176/appi.ajp.2020.20010018
FRANÇA, E. O., FERNANDES, M. L. A., SANTANA, N. M. C., & DUNNINGHAM, W. A. (2022). Fatores de risco para depressão na adolescência: uma revisão sistemática. Revista Brasileira de Neurologia e Psiquiatria, 26(1). DOI: https://doi.org/10.25118/2763-9037.2022.v12.467
GILL, H., GILL, B., EL‐HALABI, S., CHEN‐LI, D., LIPSITZ, O., ROSENBLAT, J. D., ... & MCINTYRE, R. S. (2020). Antidepressant medications and weight change: a narrative review. Obesity, 28(11), 2064-2072. DOI: https://doi.org/10.1002/oby.22969
GORYUNOV, A. V., GOLUBEVA, N. I., & SHUSHPANOVA, O. V. (2023). Experience of clinical use of fluvoxamine for the treatment of comorbid depression in childhood and adolescence. Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova, 123(11. Vyp. 2), 14-21. DOI: https://doi.org/10.17116/jnevro202312311214
KLOOSTERBOER, S. M., VIERHOUT, D., STOJANOVA, J., EGBERTS, K. M., GERLACH, M., DIELEMAN, G. C., ... & Koch, B. C. (2020). Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review. Expert Opinion on Drug Safety, 19(7), 873-890. DOI: https://doi.org/10.1080/14740338.2020.1770224
LEE, H., SONG, M., LEE, J., KIM, J. B., & LEE, M. S. (2020). Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder. Journal of affective disorders, 266, 57-62. DOI: https://doi.org/10.1016/j.jad.2020.01.125
LINEHAM, A., AVILA-QUINTERO, V. J., BLOCH, M. H., & DWYER, J. (2024). Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression. Journal of Child and Adolescent Psychopharmacology. DOI: https://doi.org/10.1089/cap.2023.0047
LINEHAM, A., AVILA-QUINTERO, V. J., BLOCH, M. H., & DWYER, J. (2023). The relationship between acute dissociative effects induced by ketamine and treatment response in adolescent patients with treatment-resistant depression. Journal of Child and Adolescent Psychopharmacology, 33(1), 20-26. DOI: https://doi.org/10.1089/cap.2022.0086
LIU, C. C., LAN, C. C., & CHEN, Y. S. (2024). The use of sertraline to treat an adolescent of dystonia comorbid with major depressive disorder with psychotic features. Neuropsychopharmacology Reports, 44(1), 275-279. DOI: https://doi.org/10.1002/npr2.12401
MENDES, K. D. S., SILVEIRA, R. C. D. C. P., & GALVÃO, C. M. (2019). Uso de gerenciador de referências bibliográficas na seleção dos estudos primários em revisão integrativa. Texto & Contexto-Enfermagem, 28, e20170204.
OLIVA, V., LIPPI, M., PACI, R., DEL FABRO, L., DELVECCHIO, G., BRAMBILLA, P., ... & SERRETTI, A. (2021). Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: a systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 109, 110266. DOI: https://doi.org/10.1016/j.pnpbp.2021.110266
RAN, L. Y., LIU, X. Y., WANG, W., TAO, W. Q., XIANG, J. J., ZENG, Q., ... & KUANG, L. (2024). Personality traits predict treatment outcome of an antidepressant in untreated adolescents with depression: An 8-week, open-label, flexible-dose study. Journal of Affective Disorders, 350, 102-109. DOI: https://doi.org/10.1016/j.jad.2024.01.015
SAHA, K., TOROUS, J., KICIMAN, E., & DE CHOUDHURY, M. (2021). Understanding side effects of antidepressants: large-scale longitudinal study on social media data. JMIR mental health, 8(3), e26589. DOI: https://doi.org/10.2196/26589
SANTOS, C. M. D. C., PIMENTA, C. A. D. M., & NOBRE, M. R. C. (2007). A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Revista latino-americana de enfermagem, 15, 508-511. DOI: https://doi.org/10.1590/S0104-11692007000300023
SILVA, O. R. T., & DA SILVEIRA, M. M. (2019). O uso de psicofármacos por crianças e adolescentes em um Centro de Atenção Psicossocial Infantil. Infarma-Ciências Farmacêuticas, 31(3), 210-218. DOI: https://doi.org/10.14450/2318-9312.v31.e3.a2019.pp210-218
STUTZMAN, D. L. (2021). Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing. Mental Health Clinician, 11(6), 320-333. DOI: https://doi.org/10.9740/mhc.2021.11.320
TENG, T., ZHANG, Z., YIN, B., GUO, T., WANG, X., HU, J., ... & ZHOU, X. (2022). Effect of antidepressants on functioning and quality of life outcomes in children and adolescents with major depressive disorder: a systematic review and meta-analysis. Translational Psychiatry, 12(1), 183. DOI: https://doi.org/10.1038/s41398-022-01951-9
ZHANG, C., ZAFARI, Z., SLEJKO, J. F., CASTILLO, W. C., REEVES, G. M., & DOSREIS, S. (2023). Impact of undertreatment of depression on suicide risk among children and adolescents with major depressive disorder: A microsimulation study. American journal of epidemiology, 192(6), 929-938. DOI: https://doi.org/10.1093/aje/kwad022
ZUANAZZI, C. A., & GRAZZIOTIN, N. A. (2020). Análise da dispensação de antidepressivos e ansiolíticos em uma farmácia comercial do Noroeste do Rio Grande do Sul. Revista Perspectiva, 44(165), 153-160. DOI: https://doi.org/10.31512/persp.v.44.n.165.2020.80.p.153-160
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
